Neumora Therapeutics Funding: $500M Raised, Series A (2021)

Neumora Therapeutics funding overview

Neumora Therapeutics is based in Watertown, Massachusetts. Neumora Therapeutics has raised $500M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series A announced in October 2021. The round record for Neumora Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include ARCH Venture Partners, Alexandria Venture Investments, Altitude Life Science Ventures, Catalio Capital Management, F-Prime Capital, Invus and 8 others. 14 distinct backers are named across the disclosed rounds.

Neumora Therapeutics at a glance

Total raised: $500M
Latest round: Series A
Latest round date: October 2021
Headquarters: Watertown, Massachusetts
Notable investors: ARCH Venture Partners, Alexandria Venture Investments, Altitude Life Science Ventures, Catalio Capital Management, F-Prime Capital, Invus, Logos Capital, Mubadala Capital

Frequently asked about Neumora Therapeutics funding

How much has Neumora Therapeutics raised?: Neumora Therapeutics has raised $500M in total disclosed funding across the rounds on record.
Who has invested in Neumora Therapeutics?: ARCH Venture Partners, Alexandria Venture Investments, Altitude Life Science Ventures, Catalio Capital Management, F-Prime Capital, Invus are named among the investors backing Neumora Therapeutics.
What was the latest Neumora Therapeutics funding round?: The most recent disclosed round is a Series A, announced in October 2021.
Where is Neumora Therapeutics based?: Neumora Therapeutics is based in Watertown, Massachusetts.
When did Neumora Therapeutics last raise?: The last disclosed Neumora Therapeutics round closed in October 2021 at Series A.

Round data for Neumora Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Watertown and backer lists below.

Neumora Therapeutics Funding: $500M Raised, Series A (2021)

Neumora Therapeutics funding overview

Neumora Therapeutics at a glance

Frequently asked about Neumora Therapeutics funding

Companies related to Neumora Therapeutics (36)

Browse related funding lists (7)